Destination XL Group (DXLG) Holiday Comps Increase 3%

Destination XL Group, Inc. (NASDAQ: DXLG), the largest omni-channel specialty retailer of big & tall men's apparel, today announced that total sales for the 9-week holiday sales period ended December 30, 2017 increased 3.5% to $101.3 million as compared to $97.9 million for the same period of the prior year. Comparable sales for the same period increased 3.0%.

November/December Sales by Month:

• For November, total sales increased 2.2% to $37.4 million compared to $36.6 million last year. Comparable sales for November increased 0.9% compared to a decline of 0.9% last year.
• For December, total sales increased 4.2% to $63.9 million compared to $61.3 million last year. Comparable sales for December increased 4.3% compared to a decline of 1.7% last year.

Based on the holiday sales results and expectations for the remainder of the fourth quarter, the Company expects to achieve the low-end of the range of its previously announced guidance for fiscal 2017. The Company plans to report its actual fourth-quarter and fiscal 2017 financial results on March 23, 2018, when management will also conduct its quarterly conference call to discuss its results for fiscal 2017, as well as its fiscal 2018 outlook.

Destination XL Group, Inc. will participate in the 2018 ICR Conference to be held at the JW Marriott Orlando Grande Lakes in Orlando, Florida on January 8-10, 2018. Management is scheduled to present on Monday, January 8, 2018 at 10:00 a.m. Eastern Time. The presentation will be hosted by David Levin, President and Chief Executive Officer, and Peter Stratton, Executive Vice President, Chief Financial Officer, and Treasurer. The presentation will be available to interested parties via a live audio webcast at http://wsw.com/webcast/icr4/dxlg.

The presentation will be webcast live and available for replay in the Investor Relations section of Destination XL's website at investor.destinationxl.com

You May Also Be Interested In

• Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan
• Ligand completes $739M acquisition of XOMA Royalty
• HCA Healthcare cuts 2026 profit outlook on insurance exchange losses